StaceyNicoleAkersMD

PubMed

• 94 citations
  Efficacy and Safety of Pembrolizumab in Combination With Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Ovarian Cancer: A Phase 2 Nonra...
  Emese Zsiros, Sarah Lynam, Kristopher Attwood, Chong Wang, Shanmuga Reddy Chilakapati, Eduardo Cortes Gomez, Song Liu, S.N. Akers, Shashikant Lele, Peter J. Frederick,...> ;JAMA Oncology. 2021 Jan 1
• 41 citations
  Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability
  Wa Zhang, David Klinkebiel, Carter J. Barger, Sanjit Pandey, Chittibabu Guda, Austin Miller, S.N. Akers, Kunle Odunsi, Adam R. Karpf> ;Cancers. 2020 Mar 24
• Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
  Dy, G. K.,Nesline, M. K.,Papanicolau-Sengos, A.,DePietro, P.,LeVea, C. M.,Early, A.,Chen, H.,Grand'Maison, A.,Boland, P.,Ernstoff, M. S.,Edge, S.,Akers, S.,Opyrchal, M...> ;BMC Med Inform Decis Mak. 2019 Jan 20
• 86 citations
  Ultrarestrictive Opioid Prescription Protocol for Pain Management After Gynecologic and Abdominal Surgery.
  Jaron Mark, Deanna Argentieri, Camille A. Gutierrez, Kayla Morrell, Kevin H. Eng, Alan D. Hutson, P.C. Mayor, J. Brian Szender, Kristen Starbuck, Sarah Lynam, Bonnie L...> ;JAMA Network Open. 2018 Dec 7
• Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease.
  Strohl A, Mori K, Akers S, Bshara W, Buttin B, Frederick PJ, Helenowski IB, Morrison CD, Odunsi K, Schink JC, Scholtens DM, Wei J, Kim JJ> ;J Ovarian Res. 2016-11-03
• DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer.
  Klinkebiel D, Zhang W, Akers SN, Odunsi K, Karpf AR> ;Mol. Cancer Res.. 2016-09-01
• 28 citations
  Evaluation of the National Surgical Quality Improvement Program Universal Surgical Risk Calculator for a gynecologic oncology service.
  J. Brian Szender, Peter J. Frederick, Kevin H. Eng, S.N. Akers, Shashikant Lele, Kunle Odunsi> ;International Journal of Gynecological Cancer. 2015 Mar 1
• DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
  Zhang W, Barger CJ, Link PA, Mhawech-Fauceglia P, Miller A, Akers SN, Odunsi K, Karpf AR> ;Epigenetics. 2015-01-01
• 145 citations
  Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.
  Kunle Odunsi, Junko Matsuzaki, Smitha R. James, Paulette Mhawech-Fauceglia, Takemasa Tsuji, Austin Miller, Wa Zhang, S.N. Akers, Elizabeth A. Griffiths, Anthony Miliot...> ;Cancer Immunology Research. 2014 Jan 1
• 38 citations
  LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients
  S.N. Akers, Kirsten B. Moysich, Wa Zhang, Golda Collamat Lai, Austin Miller, Shashikant Lele, Kunle Odunsi, Adam R. Karpf> ;Gynecologic Oncology. 2014 Feb 1
• 2 citations
  Adjuvant treatment for uterine leiomyosarcoma.
  S.N. Akers, Adrienne Groman, Kunle Odunsi, Shashikant Lele, Peter J. Frederick> ;European Journal of Gynaecological Oncology. 2013 Jan 1
• Prospective analysis of chemotherapy-induced neuropathy in patients with gynecologic malignancies.
  Riebandt G, Rodabaugh KJ, Pietkiewicz J, Fong MK, Groman AE, Lele SB, Odunsi K, Akers S> ;J. Clin. Oncol.. 2011-05-20
• Coordinated Cancer Germline Antigen Promoter and Global DNA Hypomethylation in Ovarian Cancer: Association with the BORIS/CTCF Expression Ratio and Advanced Stage.
  Woloszynska-Read, A., Zhang, W., Yu, J., Link, P.A., Mhawech-Fauceglia, P., Collamat, G., Akers, S.N., Ostler, K.R., Godley, L.A., Odunsi, K., Karpf, A.R.> ;Clin Cancer Res. 2011 Apr 15
• 3 citations
  Bevacizumab for the treatment of recurrent ovarian cancer: a retrospective cohort study.
  S.N. Akers, G. Riebandt, Miller A, Adrienne Groman, Kunle Odunsi, Shashikant Lele> ;European Journal of Gynaecological Oncology. 2013 Jan 1
• 23 citations
  Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer.
  Paulette Mhawech-Fauceglia, Joshua P. Kesterson, Dan Wang, S.N. Akers, Nefertiti C. duPont, Shashikant Lele, Song Liu> ;Histopathology. 2011 Jul 1
• 80 citations
  Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy
  S.N. Akers, Kunle Odunsi, Adam R. Karpf> ;Future Oncology. 2010 May 13
• Join now to see all